While single-target drugs have reached the market faster in China due to earlier research, multi-target drugs are expected to have stronger long-term effects and greater market acceptance
The constant switching prevents the body from establishing a predictable rhythm and makes side effects harder to manage
In the 2019 ESC/EASD Guidelines, lixisenatide and exenatide are mentioned as neutral in terms of their effect on the risk of hospitalization for HF and may be considered for the treatment of T2DM combined with HF, with a grade of recommendation of IIb
Polyphenol-rich foods like dark chocolate, green tea, and berries may also help preserve GLP-1 activity after meals
Because retatrutide isn't FDA-approved, shoppers can run into websites that blur the line between research material and real patient care
Retatrutide is different because it is designed to target three receptors: GLP-1, GIP, and glucagon